transurethral ureteroscopy
Conditions
Interventions
control group:Intravenous injection of propofol and sufentanil
Sponsors
The First Affiliated Hospital of Zhengzhou University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients aged from 18 to 60 with unlimited gender; 2. The patients who are operated on by transurethral ureteroscopy; 3. Patients with ASA grade I or II; 4. 18.0 kg / m2 <= BMI <= 30.0 kg / m2.
Exclusion criteria
Exclusion criteria: 1. Patients who refuse to participate or are not suitable to participate in the test; 2. Patients who are allergic to propofol or esmketamine; 3. Patients with ketamine use contraindications such as severe refractory hypertension, cor pulmonale, hyperthyroidism, epilepsy, increased intraocular pressure, increased intracranial pressure or intracranial space occupying lesions, and history of cerebrovascular accidents; 4. Patients with obstructive sleep apnea hypopnea syndrome or BMI > 30 kg / m2 or with difficulty in respiratory tract; 5. Patients who had a history of drinking alcohol or taking psychoactive drugs or analgesics within 24 hours before operation; 6. Patients with a history of chronic pain; 7. Objects during pregnancy or lactation; 8. Epileptic patients; 9. Patients who use drugs that affect the central nervous system; 10. Patients with previous psychological diseases such as severe depression and history of mental and neurological diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anesthesia recovery time; | — |
Secondary
| Measure | Time frame |
|---|---|
| vital signs;Adverse reactions;Irritation of indwelling catheter; | — |
Countries
China
Contacts
Public ContactDan Cheng
The First Affiliated Hospital of Zhengzhou University
Outcome results
None listed